E
Oruka Therapeutics, Inc. ORKA
$14.51 -$0.925-5.99% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Total Cash And Short-Term Investments 2,071.85% 1,158.31%
Total Receivables -- --
Inventory -- --
Prepaid Expenses 153.05% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 1,873.79% 1,169.09%

Total Current Assets 1,873.79% 1,169.09%
Net Property, Plant & Equipment 125.23% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -95.63% -78.89%
Total Assets 1,671.33% 1,235.81%

Total Accounts Payable 80.85% 88,525.00%
Total Accrued Expenses -77.31% -7.92%
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 981.97% --
Total Finance Division Other Current Liabilities 618.37% 1,041.13%
Total Other Current Liabilities 618.37% 1,041.13%
Total Current Liabilities -37.45% 63.61%

Total Current Liabilities -37.45% 63.61%
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 80.11% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities -70.20% -61.72%

Common Stock & APIC 138,553.39% 2,591,694.44%
Retained Earnings -340.99% -1,379.77%
Treasury Stock & Other -- --
Total Common Equity 1,275.64% 5,225.29%

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 0.00% 0.00%
Preferred Stock, Others -- --
Total Preferred Equity 0.00% 0.00%

Total Common Equity 1,275.64% 5,225.29%
Total Preferred Equity 0.00% 0.00%
Total Minority Interest -- --
Total Equity 1,419.16% 8,935.39%